Biodefense & Emerging Infectious Diseases
As infectious disease threats like Zika and Ebola emerge, Battelle is uniquely positioned to provide advanced expertise and capabilities to accelerate scientific discovery for infectious disease research, efficacy and safety, testing and evaluation.
Leveraging industry-leading facilities, equipment, methods, models and scientists, we offer valuable analysis and assessment for vaccines, prophylactic compounds and therapeutics for a wide array of infectious diseases, medical countermeasures and biological threats.
Battelle conducts quality biomedical research for government, industry and academia and is one of only a few high-containment facilities in the nation capable of conducting Good Laboratory Practices (GLP)-compliant safety and efficacy testing in a variety of large and small in vivo models.
Multiple Scientific Disciplines for Reliable Results
From biology to chemistry to bioengineering and everything in between, our experts engage in groundbreaking work with bacteria, viruses and toxins to meet the unique needs of our clients. This multidisciplinary process enables Battelle to provide quality results on time and within budget.
Battelle utilizes world-class expertise in efficacy (vaccine, therapeutic and prophylactic) and safety testing and the latest in genomic and proteomic biomarker discovery and characterization capabilities to create value-added solutions for our clients. Our biomarker capabilities and experience with in vitro and in vivo model development accelerate the development of breakthrough drugs and diagnostics.